Three-month survival of HDAFF transgenic pig hearts transplanted into primates

Transplantation Proceedings

Volumn 31, Issue 1-2, 1999, Pages 958-

  Bhatti, F N K ^a   Schmoeckel, M ^a   Zaidi, A ^a   Cozzi, E ^a   Chavez, G ^a   Goddard, M ^b   Dunning, J J ^a   Wallwork, J ^b   White, D J G ^a  

^a Imutran Ltd (A Novartis Pharma AG C   (United Kingdom)

^b PAPWORTH HOSPITAL   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

CYCLOPHOSPHAMIDE; CYCLOSPORIN A; DECAY ACCELERATING FACTOR; IMMUNOSUPPRESSIVE AGENT; MYCOPHENOLIC ACID 2 MORPHOLINOETHYL ESTER; STEROID;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; BABOON; CONFERENCE PAPER; CONTROLLED STUDY; DRUG TOLERABILITY; GRAFT REJECTION; GRAFT SURVIVAL; HEART TRANSPLANTATION; IMMUNOHISTOCHEMISTRY; IMMUNOSUPPRESSIVE TREATMENT; INFECTION; INTRAVENOUS DRUG ADMINISTRATION; NONHUMAN; PRIORITY JOURNAL; SURVIVAL RATE; SWINE; TRANSGENIC ANIMAL;

ANIMALS; ANIMALS, GENETICALLY MODIFIED; ANTIGENS, CD; ANTIGENS, CD55; CYCLOSPORINE; DRUG THERAPY, COMBINATION; GRAFT REJECTION; GRAFT SURVIVAL; HEART TRANSPLANTATION; HUMANS; IMMUNOSUPPRESSIVE AGENTS; MYCOPHENOLIC ACID; PAPIO; SWINE; TIME FACTORS; TRANSPLANTATION, HETEROLOGOUS;

EID: 0345561689     PISSN: 00411345     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0041-1345(98)01855-7     Document Type: Conference Paper

References (2)

1. Waterworth P.D., Cozzi E., Tolan M.J., et al. Transplant Proc. 29:1997;899.
2. Stark J.H., Smit J.A., Gridelli B. Transplant Int. 7:1994;372.